Recent findings indicated that SARS-CoV-2 related neurological manifestations involve cytokine release syndrome along with endothelial activation, blood brain barrier dysfunction, and immune-mediated mechanisms. Very few studies have fully investigated the CSF correlates of SARS-CoV-2 encephalitis.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses / Pilotto, Andrea; Masciocchi, Stefano; Volonghi, Irene; De Giuli, Valeria; Caprioli, Francesca; Mariotto, Sara; Ferrari, Sergio; Bozzetti, Silvia; Imarisio, Alberto; Risi, Barbara; Premi, Enrico; Benussi, Alberto; Focà, Emanuele; Castelli, Francesco; Zanusso, Gianluigi; Monaco, Salvatore; Stefanelli, Paola; Gasparotti, Roberto; Zekeridou, Anastasia; Mckeon, Andrew; Ashton, Nicholas J; Blennov, Kaj; Zetterberg, Henrik; Padovani, Alessandro. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - ELETTRONICO. - 73:9(2021), pp. e3019-e 3026. [10.1093/cid/ciaa1933]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses
Benussi, Alberto;
2021-01-01
Abstract
Recent findings indicated that SARS-CoV-2 related neurological manifestations involve cytokine release syndrome along with endothelial activation, blood brain barrier dysfunction, and immune-mediated mechanisms. Very few studies have fully investigated the CSF correlates of SARS-CoV-2 encephalitis.| File | Dimensione | Formato | |
|---|---|---|---|
|
33395482.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
3.6 MB
Formato
Adobe PDF
|
3.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
